Tevapharm India Private Limited — Telmisartan Exporter Profile
Indian Pharmaceutical Exporter · #12 for Telmisartan · $3.3M export value · DGFT Verified
Tevapharm India Private Limited is the #12 Indian exporter of Telmisartan with $3.3M in export value and 93 verified shipments. Tevapharm India Private Limited holds a 0.6% market share in Telmisartan exports across 3 countries.
Tevapharm India Private Limited — Telmisartan Export Profile: Buyers & Destinations
Where Does Tevapharm India Private Limited Export Telmisartan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| HUNGARY | $2.7M | 75 | 84.1% |
| CANADA | $341.0K | 11 | 10.4% |
| CROATIA | $177.3K | 7 | 5.4% |
Tevapharm India Private Limited exports Telmisartan to 3 countries. The largest destination is HUNGARY accounting for 84.1% of Tevapharm India Private Limited's Telmisartan shipments, followed by CANADA (10.4%) and CROATIA (5.4%). These destinations reflect Tevapharm India Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Telmisartan from Tevapharm India Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TEVA PHAMACEUTICALS WORKS | HUNGARY | $2.7M | 75 |
| TEVA CANADA LIMITED | CANADA | $341.0K | 11 |
| PLIVA HRVATSKA D.O.O. FTOZ | CROATIA | $177.3K | 7 |
Tevapharm India Private Limited supplies Telmisartan to 3 buyers globally. The largest buyer is TEVA PHAMACEUTICALS WORKS (HUNGARY), followed by TEVA CANADA LIMITED (CANADA) and PLIVA HRVATSKA D.O.O. FTOZ (CROATIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Telmisartan Export Value and How Much Does Tevapharm India Private Limited Contribute?
India exported $172.2M worth of Telmisartan through 11,086 shipments from 413 suppliers to 132 countries, serving 1,116 buyers globally. Tevapharm India Private Limited contributes $3.3M to this total, accounting for 0.6% of India's Telmisartan exports. Tevapharm India Private Limited ships Telmisartan to 3 countries through 3 buyers.
What Is the Average Shipment Value for Tevapharm India Private Limited's Telmisartan Exports?
Tevapharm India Private Limited's average Telmisartan shipment value is $35.3K per consignment, based on 93 shipments totaling $3.3M. The largest destination is HUNGARY (84.1% of Tevapharm India Private Limited's Telmisartan exports).
How Does Tevapharm India Private Limited Compare to Other Indian Telmisartan Exporters?
Tevapharm India Private Limited ranks #12 among 413 Indian Telmisartan exporters with a 0.6% market share. The top 3 exporters are CIPLA LIMITED ($81.0M), INTAS PHARMACEUTICALS LIMITED ($15.5M), MYLAN LABORATORIES LIMITED ($12.0M). Tevapharm India Private Limited processed 93 shipments to 3 destination countries.
What Telmisartan Formulations Does Tevapharm India Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| 221791,TELMISARTAN 80MG T FASS (TPW) F,V | $611.6K | 17 |
| 221790,TELMISARTAN 40MG T FASS (TPW) F,V | $185.4K | 5 |
| TELMISARTAN 20MG FT EU FASS F VK IN T | $129.7K | 5 |
| TELMISARTAN 80MG T FASS TPW F VK IN T | $102.5K | 3 |
| 198412, TEVA-TELMISARTAN 40 MG T.FASS F, | $100.7K | 4 |
| 221790 TELMISARTAN 40MG T FASS TPW F VK IN T BATCH NO 1230077 QTY 1572 457 | $100.0K | 2 |
| 221790 TELMISARTAN 40MG T FASS TPW F VK IN T BATCH NO 1230076 QTY 1568 964 | $100.0K | 2 |
| 221790 TELMISARTAN 40MG T FASS TPW F VK IN T BATCH NO 1230075 QTY 1567 698 | $100.0K | 2 |
| 247207, TELMISARTAN 80/12.5MG T(EIMER) F | $91.2K | 3 |
| 235501 TELMISARTAN 20MG FT (EU) FASS F,V | $90.9K | 4 |
Tevapharm India Private Limited exports 47 distinct Telmisartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is 221791,TELMISARTAN 80MG T FASS (TPW) F,V with 17 shipments worth $611.6K.
Regulatory Requirements: Exporting Telmisartan to Key Markets
What Tevapharm India Private Limited must comply with to export Telmisartan to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Tevapharm India Private Limited Compare to Nearest Telmisartan Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | INVENTIA HEALTHCARE LIMITED | $5.3M | 197 | 8 | $26.8K |
| 11 | TORRENT PHARMACEUTICALS LTD | $3.7M | 98 | 7 | $37.7K |
| 12 | TEVAPHARM INDIA PRIVATE LIMITED ★ | $3.3M | 93 | 3 | $35.3K |
| 13 | MARKSANS PHARMA LIMITED | $1.4M | 29 | 3 | $50.0K |
| 10 | MEDIWIN PHARMACEUTICALS | $1.3M | 26 | 3 | $50.0K |
Tevapharm India Private Limited ranks #12 among 413 Indian Telmisartan exporters. Average shipment value of $35.3K compared to the market average of $416.8K. The closest competitors by value are INVENTIA HEALTHCARE LIMITED and TORRENT PHARMACEUTICALS LTD.
Which Indian Ports Ship Telmisartan Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,766 | 15.9% |
| SAHAR AIR | 1,729 | 15.6% |
| DELHI AIR CARGO ACC (INDEL4) | 1,003 | 9.0% |
| NHAVA SHEVA SEA (INNSA1) | 755 | 6.8% |
| DELHI AIR | 623 | 5.6% |
| AHEMDABAD AIR | 402 | 3.6% |
| Bombay Air | 396 | 3.6% |
| JNPT | 377 | 3.4% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Telmisartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Telmisartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Tevapharm India Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 93 individual customs records matching Tevapharm India Private Limited exporting Telmisartan, covering 47 formulations to 3 countries via 3 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 132+ countries, 1,116+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Telmisartan Export Data from Tevapharm India Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Tevapharm India Private Limited's Telmisartan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Tevapharm India Private Limited
Company Profile
0 products · $0 total trade · 0 categories
Telmisartan Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Tevapharm India Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Telmisartan. For current shipment-level data, contact TransData Nexus.